Treatments for moderate and severe dengue
Treatments studied
Part of Infections clinical trials.
This trial tests new treatments for people hospitalized with moderate to severe dengue, a mosquito-borne illness. It aims to find better ways to reduce symptoms and prevent serious complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 5 years old or older
- You have been diagnosed with dengue by a doctor
- You need to be admitted to the hospital
- You have at least one sign of severe dengue, such as severe belly pain, frequent vomiting, fluid build-up, low platelets, or bleeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new strategies to treat dengue, ranging from mild to severe cases. It may help people with different stages of dengue find better care and support.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This trial studies whether dexamethasone (a steroid medicine) can help people with dengue infection who have warning signs and are still in the fever stage. It may help reduce complications like breathing problems, severe bleeding, or organ stress, but it is only for a specific window and situation.
This trial tests whether a medicine called emetine can help adults hospitalized with dengue. If you have a confirmed dengue infection and symptoms like fever, headache, or body aches, this study may be for you.
This trial tests whether a new medicine called CP-COV03 can help people recover faster from dengue fever or dengue-like illness. You would receive either the study medicine or a placebo (inactive pill) and be monitored closely to see if symptoms improve.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.